Rhinovirus infections cause over one third of all colds and are a contributing factor to exacerbations of asthma. To gain insights into the early biochemical events that occur in infected epithelial cells, we develop, for the first time, a model in which a pure respiratory epithelial cell population can be routinely infected by rhinovirus. Viral infection was confirmed by demonstrating that viral titers of supernatants and lysates from infected cell increased with time and by PCR. Infection by rhinovirus 14 was inhibited by homotypic antiserum and by antibodies to intercellular adhesion molecule-i (ICAM-1), the receptor for this virus. Susceptibility of epithelial cells to infection by rhinovirus 14 (but not rhinovirus 2, an ICAM-1 independent strain) can be increased by preexposure of cells to TNFa, whereas IFNy reduces susceptibility to infection by both rhinovirus strains. Rhinovirus infection per se does not markedly alter ICAM-1 expression on epithelial cells. Finally, we demonstrate that rhinovirus infection induced increased production of IL-8, IL-6, and GM-CSF from epithelial cells. Production of IL-8 correlated with viral replication during the first 24 h after infection. This model should provide useful insights into the pathogenesis of rhinovirus infections. (J. Clin. Invest. 1995. 96:549-557.)
Introduction
Rhinovirus infections are responsible for over 30% of all the common colds experienced each year (1) . Moreover, it is becoming increasingly recognized that rhinovirus infection can be a precipitating or exacerbating factor of other diseases, including asthma (2) (3) (4) , chronic bronchitis (4, 5) , sinusitis (6, 7) , and otitis media (8) . Despite the high prevalence of rhinovirus TCID, tissue culture infective dose.
infections, the pathogenesis of the subsequent disease process is incompletely understood.
Several lines of evidence indicate that the respiratory epithehal cell is the primary site of rhinovirus infection in humans.
Intercellular adhesion molecule-i (ICAM-1), 1 the receptor for the major group of rhinoviruses (9, 10) , is known to be expressed by epithelial cells ( 11 ) . Moreover, during colds, rhinovirus has been detected, in a limited number of shed epithelial cells, by indirect immunofluorescence ( 12) , as well as in epithelial cells from biopsies of infected subjects by in situ hybridization (13). In contrast to infections with viruses such as influenza, rhinovirus infections result in no obvious changes in the morphology or integrity of the nasal epithelium (14) , implying that symptoms are unlikely to be due to cytotoxic effects of the virus. It has been shown, however, that levels of inflammatory mediators, including kinins (15, 16 ) and IL-1 (17) , are increased in nasal secretions of subjects with symptomatic colds, and it is known that symptomatic rhinovirus infections are associated with increased numbers of neutrophils both in the nasal mucosa (14) and in recovered nasal secretions (15, 18) . Furthermore, the severity of nasopharyngeal symptoms in experimental colds also correlates with the numbers of lymphocytes in nasal secretions (18) . Although the sequence of events leading from infection to the manifestation of symptoms, generation of mediators, and recruitment of cells remains unknown, it seems reasonable to hypothesize that this sequence of events must be initiated as a result of changes in the biochemistry of infected epithelial cells. If this is indeed the case, then delineation of such biochemical changes is of obvious importance for the development of improved therapeutic approaches to the management of rhinovirus infections and their complications. To perform such studies, however, it is clearly critical to be able to routinely infect respiratory epithelial cells with rhinovirus in a setting independent of other cell types that are normally present in the airway mucosa.
We now report a method by which a pure human respiratory epithelial cell line can be routinely infected with rhinovirus and present initial studies on the regulation of susceptibility to viral infection by preexposure to cytokines. Moreover, we demonstrate that infection of these cells with rhinovirus leads to increased production of proinflammatory cytokines that could play a role in the pathogenesis of symptomatic infections.
Methods
Viruses, viral antisera, cell lines, and media components. Human rhinovirus types 14 (HRV-14) and 2 (HRV-2), HeLa cells, and guinea pig polyclonal antisera to HRV-14 and HRV-2 were purchased from American Type Culture Collection (Rockville, MD). The BEAS-2B cell line was kindly provided by Dr. Curtis Harris (National Cancer Institute, Bethesda, MD). This cell line was derived from normal human bronchial epithelial cells by transfection with an adenovirus hybrid virus (19) . Reagents for culture media were obtained as follows: Ham's F-12 medium, and penicillin/streptomycin/fungizone (GIBCO Laboratories, Grand Island, NY); insulin, hydrocortisone, EGF, endothelial cell growth supplement, and triiodothyronine (Collaborative Research, Bedford, MA); cholera toxin (Sigma Chemical Co., St. Louis, MO); and DME supplemented with 10% FBS (Biofluids, Rockville, MD).
Epithelial cell culture. The BEAS-2B cells used in our studies were cultured as previously described (20) and were used between passages 35 and 50. Cells were plated on 6-well plates (Costar, Cambridge, MA) at a density of 2.5 x 104 cells/cm2 in a serum-free medium consisting of Ham's F-12 nutrient medium that contained penicillin, streptomycin, and fungizone (100 U/ml, 100 U/ml, and 250 ng/ml, respectively), insulin (5 Mg/ml), hydrocortisone ( I0-7 M), EGF ( 12.5 ng/ml), endothelial cell growth supplement (3.75 ag/ml), triiodothyronine (3 x I0-9 M), and cholera toxin (10 ng/ml). This medium is referred to as F12/ 6X. The cells were incubated at 370C in humidified air that contained 5% C02-Viral stocks. A stock solution of HRV-14 was generated by infecting monolayer cultures of HeLa cells. Cultures were grown in DME/FBS for several days until cytopathic effects were obvious, after which the cultures were frozen at -70'C, thawed, and sonicated. The virus-containing fluid so obtained was frozen in aliquots at -70'C. The content of viral stock solutions was determined using the HeLa cell assay described below. Because of the limited number of studies performed with HRV-2, stocks of this virus were used directly as obtained from the supplier.
Detection and titration of viruses. Rhinoviruses were detected by exposing confluent monolayers of HeLa cells in 96-well plates to serial 10-fold dilutions of virus-containing medium or lysates in Ham's F-12/ 10% FBS. Plates were then incubated at 34°C for 5 d after which the medium was removed, and cells were washed with 100 Ml of PBS and fixed by adding 50 M1 of methanol per well for 1 min. The methanol was then replaced with 100 Ml of 0.1% crystal violet in distilled water for 20 min. Plates were washed, and absorbance at 570 nM was measured using a plate reader. The amount of specimen required to infect 50% of monolayers (TCID50) was determined. Specificity was confirmed by showing that preincubation of viral medium with a serotypespecific rhinovirus antibody, but not with an irrelevant antibody, for 30 min blocked the cytopathic effect on HeLa cells.
Viral infection of BEAS-2B cells. Medium was removed from subconfluent monolayers of BEAS-2B cells and was replaced with 2 ml HBSS (Biofluids). Rhinovirus was added at appropriate concentrations. For routine infections, a concentration of 102.5 TCID50/ml was used. After a 1-h incubation at 34°C, the viral solution was removed and the cells were washed once with 2 ml of fresh HBSS. Cells were then fed with F12/6X and incubated at 34°C. Supernatants were removed at various times after infection and stored at -70°C for determination of viral content. Viral titers of the material used for infection and of the supernatants removed at the end of the infection period were also determined to estimate the maximal amount of viral uptake that had occurred during the exposure period. As an additional control for nonspecific adherence of virus, the content of inocula after a 1-h incubation in empty wells was also assessed. Finally, cell-associated viral content was also analyzed using sonicated BEAS-2B cells.
Effect of type-specific antisera on HRV-14 infection. HRV-14 ( 102.5 TCID50/ml) was incubated for 30 min with a 1:10 dilution of antiserum to HRV-14. The virus was then incubated with BEAS-2B cell monolayers at 34°C for 15 min in 95% air-5% CO2 before washing the monolayer and culturing in F12/6X. BEAS-2B cell monolayers were also exposed for the same time period to HRV-14 that had been incubated with a 1:10 dilution of antiserum to HRV-2 or with no antibody. The viral content of the supernatant culture medium 24 h after infection was determined as described above. bp. The identity of the PCR product was confirmed by Southern blotting using a labeled internal oligonucleotide probe JWA-1 (5'GCATTC-AGGGGCCGGAG3') as described previously (21) . Effects of exposure to cytokines on susceptibility to infection with rhinovirus. Because HRV-14 uses ICAM-1 as its cellular receptor, we examined the effects of cytokines that are known to increase the expression of ICAM-l on BEAS-2B cells on the susceptibility of the cells to infection HRV-14. It has been shown that TNFa and IFNy are each capable of increasing the expression of ICAM-l on BEAS-2B cells and that the effects of the two cytokines are additive (22, 23) . Monolayers of BEAS-2B cells were incubated, therefore, for 24 h with either TNFa (10 U/ml, Genzyme, Cambridge, MA), IFNy (30 U/ml, Biosource International, Camarillo, CA), or to both TNFa (10 U/ml) and IFNy (30 U/ml). These concentrations were shown earlier to be optimal for inducing ICAM-1 expression on BEAS-2B cells (23) . We also tested the effects of IFNa (30 U/ml, Biosource International) and IL-1 (1 ng/ ml, UBI, Lake Placid, NY), which do not increase ICAM-l expression on epithelial cells. After removal of cytokines, cells were exposed to serial 10-fold dilutions of virus for 1 h at 34°C. After Effects of HRV-14 infection on production of cytokines. In initial experiments, monolayers of BEAS-2B cells were infected with HRV-14 (1025 TCIDM/ml), and supernatants recovered 24 h later were analyzed for the presence of IL-8, IL-6, and GM-CSF. Based on the data obtained, supernatants recovered at differing times after viral infection during the experiments that were used to monitor viral titers were used to examine the time course of production of IL-8, the cytokine released in the greatest amounts. Levels of 11L-6 and GM-CSF in cell supernatants were assayed using commercial kits (R&D Systems, Minneapolis, MN). Levels assay provided results that were in excellent agreement with those obtained in a commercial assay (R & D Corp.).
To confirm that cytokine production was indeed due to the effects of rhinovirus infection and not to a contaminant present in the viral stock, two different types of experiments were performed to prevent infection with HRV-14. First, as described above, epithelial cells were preincubated using a monoclonal antibody (84H10) to ICAM-1 or a class-matched IgG1 control monoclonal at an identical concentration, and the effects of epithelial cell IL-8 production examined. Second, the ability of ultraviolet (UV)-inactivated virus to induce cytokine production was also examined. UV inactivation was performed as described previously (26) .
Statistical analysis. Demonstration of significant increases in viral titers was performed using a one-way ANOVA. The effects of cytokines on the dose of virus necessary to cause infections were compared using Student's t tests. Analysis of the effects of viral infection and time on the expression of ICAM-1 on BEAS-2B cells was performed using a two-way repeated measures ANOVA. A similar analysis was used to examine the effects of viral infection and time on IL-8 production. Subsequent post-hoc analysis was performed using paired Student's t tests. The effects of anti-ICAM-1 and of UV inactivation on virally induced cytokine production were compared by paired t tests after normalizing data from each experiment in terms of increases induced by virus. For all analyses, values of P < 0.05 were assumed to be significant.
Results
HRV-14 infection of BEAS-2B cells. Exposing subconfluent BEAS-2B cell monolayers to HRV-14 (1025 TCID5o/ml) consistently led to infection. In each of four experiments used to monitor viral titers, the supernatant removed after the 1-h infection period still contained 102.5 TCID50/ml of virus when assessed in the HeLa cytotoxicity assay, implying that only a small amount of virus was taken up by the cells. Subsequent collection of culture medium at differing times after viral exposure revealed no detectable virus at 1 and 4 h after infection. Virus was detected in the culture medium 8 h after infection, and the viral content progressively increased between 8 and 24 h after infection (Fig. 1, left) . Evidence of continuous viral production was obtained by demonstrating that the viral titers of supernatants collected during the second and third 24-h periods after infection each contained similar levels of virus to those detected at 24 h after infection (Fig. 1, right) . Analysis of the levels of cell-associated virus (the virus detectable in sonicates of the BEAS-2B cells) followed a similar time course to that observed in the medium (Fig. 2) . Again, these data suggested (Fig. 4) . In contrast, both IFNy and IFNa reduced the susceptibility to infection, increasing the minimum dose of HRV-14 necessary to cause infection by 10-fold. Pretreatment with IL-1 did not affect the susceptibility to infection. Interestingly, when cells were preincubated with a combination of TNFa and IFNy, the effects of IFNy predominated in that susceptibility to infection was decreased (Fig. 4) .
To evaluate the role of alterations of ICAM-1 expression in the effects of TNFa 10 -fold the minimum dose of both HRV-14 and HRV-2 that were necessary to cause infection. In contrast, although preincubation with TNFa again increased the susceptibility to infection by HRV-14, this cytokine had no effect on the minimum dose of HRV-2 that was necessary to cause infection (Fig. 5) . Effects ofHRV-14 infection on expression ofICAM-J. Flow cytometry analysis of ICAM-1 expression at differing times after incubation of cells with rhinovirus gave similar results with each of the two monoclonal antibodies used (Table I) . Even in control noninfected cells, all cells expressed ICAM-1. A small increase in ICAM-1 was seen 24 h after infection in each of three experiments, but there were no statistically significant differences when analyzed by ANOVA. Moreover, this modest increase in ICAM-1 expression was not associated with an increased capacity for neutrophil adhesion. In three experiments, adhesion of nonactivated neutrophils to infected epithelial cells was 4.1±0.3%, whereas adhesion to noninfected monolayers was 4.6±0.5%. Similarly, adherence of FMLP-activated neutrophils was 21.5±0.5% to infected monolayers and 21.0±2% to noninfected epithelial cells.
Effect of HRV-14 infection on cytokine production. An initial analysis of supernatants collected from infected and control cells at 24 h after infection showed that rhinovirus infection increases cytokine secretion (Fig. 6) . Because viral infection did not alter cell numbers (see above), all cytokine values are reported in picograms per milliliter of supernatant. Secretion of IL-8, IL-6, and GM-CSF were all increased in response to rhinovirus infection, although in terms of absolute levels, IL-8 production (2,100±200 pg/ml) predominated. Quite high levels of (1,070±202 pg/ml) were also produced, whereas GM-CSF levels (30±1 pg/ml) were markedly lower. Because IL-8 was the predominant cytokine produced, further studies were performed to relate secretion of this cytokine to viral titer levels. Aliquots of supernatants from the same experiments used to assay the viral titers shown in Fig. 1 were assayed for IL-8 (Fig. 7) . During the first 24 h after infection, 1L-8 production increased in a manner that paralleled viral titers. Statistical analysis by ANOVA demonstrated that the curves for cytokine production from infected and noninfected cells were significantly different (P < 0.05), with interactive effects of both treatment and time. Maximal 11L-8 production was seen 24 h after infection when 1,075±250 pg/ml was detected in the culture medium from infected cells compared with 410+240 pg/ml in the culture medium from control cells (P < 0.005). By repeated-measure ANOVA, there were no significant differences with respect to time or treatment between each of the 24-h collection periods. Thus, by the second and third 24-h collection periods after infection, when IL-8 production from infected cells was reduced to 525±130 and 730±175 pg/ml, respectively, these values were no longer different from those from noninfected cells (Fig. 7) .
To confirm that cytokine production was induced by rhinovirus and not by a contaminant in the viral stocks, the effects of preincubation of epithelial cells with mouse monoclonal antibody to human ICAM-1 (84H10), or an irrelevant mouse classmatched monoclonal IgG1 control, on cytokine production 24 h after viral exposure were examined. Infection of cells with HRV-14 again resulted in a stimulation of 11L-8 productiqn, almost tripling the levels seen in supernatants from noninfected cells (Fig. 8) . Incubation of cells with antibody to ICAM-1 again completely blocked viral infection, as assessed by the absence of detectable viral titers in the supernatants recovered 24 h after viral exposure (not shown). This treatment also significantly (P < 0.02) inhibited the virally induced increases in 11L-8 production. By contrast, the irrelevant IgG, monoclonal had no effect on 11L-8 production (Fig. 8) . As an additional control, the effects of UV inactivation of rhinovirus was also examined in three experiments. Spontaneous production from noninfected cells at 24 h was 375±110 pg/ml. Infection with active HRV-14 increased this to 750±120 pg/ml. By contrast, exposure to UV-inactivated virus resulted in the production of only 450±140 pg/ml of IL-8. Thus, UV inactivation significantly (P < 0.02) reduced virally induced cytokine production. This low efficiency of infection is consistent with studies performed using HeLa cells where the viral particle to infectious unit ratio was found to be as high as 800:1 (30) .
The specificity of the infection process for BEAS-2B cells by HRV-14 was confirmed by demonstrating that infection could be blocked using a homotypic neutralizing antibody but not by an antibody to an unrelated serotype, HRV-2. Similarly, monoclonal antisera directed against the functional binding site of ICAM-1, the major rhinovirus receptor, could also block infection by . In all of these experiments, however, it was necessary to restrict exposure times of cells to the virus to 15 min. At longer incubation times (e.g., 1 h), inhibition became less consistent, presumably because of the high affinity of the virus for its receptor and of the requirement for very few viral particles to enter the cell to induce infection.
Infection of BEAS-2B cells with HRV-14 was found to occur most easily when subconfluent monolayers were exposed to virus. The reasons for this are unclear. It is tempting to speculate that it may involve the relative distribution of ICAM-1 on the luminal and basolateral surfaces of cells as they become confluent, but this seems unlikely because the BEAS-2B cell is relatively undifferentiated and does not form electrically tight junctions in culture. Moreover, confluent monolayers can still (34) , and induction of nitric oxide synthase (35) . Whatever the mechanisms involved, these data are consistent with the hypothesis that the relative levels of cytokines within the airway may play a role in helping to explain the variations in susceptibility of individuals to infection. In recent years, it has become apparent that the respiratory epithelial cell plays a much more active role in regulating airway inflammation than was appreciated previously, providing support for our hypothesis that stimulation of biochemical pathways in infected epithelial cells could induce a series of events that contribute to the pathogenesis of rhinovirus infections. It is also clear from the current studies that rhinovirus infection can stimulate epithelial cell cytokine production. That the increase in cytokine production was due to viral infection and not to a contaminant, such as a cytokine, in the viral stocks was confirmed by demonstrating that the increase in cytokine production could be inhibited by blockade of infection with antibodies to ICAM-1 or by inactivation of the virus with UV light. The enhanced production of IL-8 within 24 h after infection is in good agreement with previous studies demonstrating that infection of epithelial cells with influenza (36) or respiratory syncytial virus (RSV) (37) also stimulates IL-8 production in this time frame, before the onset of demonstrable cytotoxic effects. In the case of RSV infection, however, IL-8 production was not maximal, and LL-6 and GM-CSF production were not observed, until 96 h after infection, during the RSV replicative phase. In the current studies with rhinovirus, increased IL-8 production was also correlated with viral replication during the first 24 h, and both IL-6 and GM-CSF could be detected within this time frame. In contrast to RSV, however, IL-8 production tended to decrease at subsequent time points, despite the presence of continued viral replication. This is of interest given that the symptomatic phase of rhinovirus infections usually resolves within 5-6 d after infection, even though viral shedding can still be detected several days later (38) . The cytokines produced from epithelial cells in response to viral stimulation have biological properties that are of interest with respect to the pathogenesis of colds. IL-8 is a potent chemoattractant for, and activator of, neutrophils (39) and also has chemotactic activity for lymphocytes (40) , the two predominant cell types in the nasal mucosa during rhinovirus infections (14, 18 ). IL-6 can not only induce B cell differentiation and antibody production but is also capable of stimulating T cell activation (41) . Finally, GM-CSF can prime both neutrophils and eosinophils for enhanced activation to chemical stimuli (42) , and inhalation of aerosolized GM-CSF induced infiltration of activated macrophages and neutrophils in nonhuman primates (43) . The capacity of rhinovirus to induce the production of all three of these epithelial cytokines is also of interest from the perspective of viral exacerbations of asthma, since increased epithelial expression of IL-8, IL-6, and GM-CSF has been reported in asthmatics (44) .
In 
